Tensi+ European Registry

ConditionOveractive Bladder

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorStimuli Technology

About this trial

Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Patients suffering from idiopathic or neurological overactive bladder

Disqualifiers

Patients with pacemaker, defibrillator, or any other electronic implant;

Patients with metal implant near the stimulation area;

Pregnant women;

People suffering from ankle joint problems, swollen ankles or a dermatological condition or damaged skin in the area where the electrodes are to be placed;